Back to announcement
20250721_OBAT_Laporan Penggunaan Dana Hasil Penawaran Umum_31916122.pdf
Other Text extracted OBATSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page
Nomor Surat 037/VII/PR/2025.R
Nama Perusahaan PT Brigit Biofarmaka Teknologi Tbk
Kode Emiten OBAT
Lampiran 1
Perihal Laporan Penggunaan Dana Hasil Penawaran Umum
Dana yang diperoleh dari Penawaran Umum IDR
Rencana Realisasi
Jumlah
Biaya Hasil Penggunaa Penggunaa
Hasil
Jenis Penawaran Realisasi n Dana n Dana Sisa Dana
Tanggal Penawaran
Penawaran Nama Emisi Umum Bersih Menurut Menurut (satuan
Efektif Umum
Umum (satuan mata (satuan Prospektus Prospektus mata uang)
(satuan
uang) mata uang) (satuan (satuan
mata uang)
mata uang) mata uang)
13 Januari 59.500.000.0 3.618.602.45 55.881.397.5 55.881.397.5 20.661.007.1 35.220.390.
IPO Saham OBAT
2025 00 1 49 49 47 402
Penempatan Sisa Dana
Jenis
Kode Nama
Penawaran Penempatan List
Efek
Umum
Sisa Dana Hubungan
Tingkat Bunga/ Jangka Waktu
(satuan mata Penempatan dengan
Bagi Hasil Penyimpanan
uang) Perusahaan
PT Bank Mandiri
3.955.299.013 0 % - pihak Tiga
IPO Saham OBAT Tbk
PT Bank Central
14.227.601.842 0 % - pihak Tiga
Asia Tbk
PT Bank Negara
17.037.489.546 0 % - pihak Tiga
Indonesia Tbk
Rincian Rencana Penawaran Umum
Jenis
Kode Nama
Penawaran Tanggal Efektif Rencana List
Efek
Umum
Hasil
Realisasi Jumlah
Bersih Uraian (satuan mata Persentase
(satuan mata uang)
uang)
IPO Saham OBAT 13 Januari 2025 Modal Kerja
Pembelian
Bahan Baku,
59.500.000.000 Peningkatan 59.500.000.000 100 %
Fasilitas
Produksi, dan
Pemasaran
Page 2
Rincian Realisasi Penawaran Umum
Jenis
Kode Nama
Penawaran Tanggal Efektif Realisasi List
Efek
Umum
Hasil
Realisasi Jumlah
Bersih Uraian (satuan mata Persentase
(satuan mata uang)
uang)
Modal Kerja
IPO Saham OBAT 13 Januari 2025
Pembelian
Bahan Baku,
63,020000
20.661.007.147 Peningkatan 20.661.007.147 %
45776367
Fasilitas
Produksi, dan
Pemasaran
Demikian untuk diketahui.
Hormat Kami,
PT Brigit Biofarmaka Teknologi Tbk
Is Heriyanto
Direktur Utama
PT Brigit Biofarmaka Teknologi Tbk
Jalan Raya Tawangsari-Klaten, Rejosari, RT 01, RW 07, Kateguhan,
Telepon : (0271) 5992141, Fax : , www.brigit.co.id
Nama Pengirim Is Heriyanto
Jabatan Direktur Utama
Tanggal dan Waktu 21-07-2025 11:06
Lampiran 1. Penggunaan Dana IPO signed R.pdf
Dokumen ini merupakan dokumen resmi PT Brigit Biofarmaka Teknologi Tbk yang tidak memerlukan tanda tangan
karena dihasilkan secara elektronik oleh sistem pelaporan elektronik. PT Brigit Biofarmaka Teknologi Tbk
bertanggung jawab penuh atas informasi yang tertera didalam dokumen ini.
Page 3
Go To Indonesian Page
Announcement Number 037/VII/PR/2025.R
Issuer Name PT Brigit Biofarmaka Teknologi Tbk
Issuer Code OBAT
Attachment 1
Subject Laporan Penggunaan Dana Hasil Penawaran Umum
Fund received form the public offering IDR
Amount of Plan for use Realized
Proceed Cost of of proceed Use of Fund
Type of Net Remaining
Name of from the Public according to according to
public Listing Date Realization Fund (in
Issuance Public Offering (in the the
offering (in Currency) Currency)
Offering (in Currency) Prospectus Prospectus
Currency) (in Currency) (in Currency)
59,500,000,0 3,618,602,45 55,881,397,5 55,881,397,5 20,661,007,1 35,220,390,
IPO Saham OBAT
00 1 49 49 47 402
Allocation of Remaining Fund
Type of public Name / Code of
List of allocation
offering Securities
Remaining Fund Interest/Yield Relationship with
Allocation Retention Period
(in Currency) Rate the company
PT Bank Mandiri
3,955,299,013 0 % - pihak Tiga
IPO Saham OBAT Tbk
PT Bank Central
14,227,601,842 0 % - pihak Tiga
Asia Tbk
PT Bank Negara
17,037,489,546 0 % - pihak Tiga
Indonesia Tbk
Details of Public Offering Plan
Type of public Name / Code of
Listing date List of plans
offering Securities
Net Realization Amount (in
Description Percentage
(in Currency) Currency)
IPO Saham OBAT Modal Kerja
Pembelian
Bahan Baku,
59,500,000,000 Peningkatan 59,500,000,000 100 %
Fasilitas
Produksi, dan
Pemasaran
Page 4
Details of Public Offering Realization
Type of Public Name / Code of
Listing Date Realization Plan
Offering Securities
Net Realization Amount (in
Description Percentage
(in Currency) Currency)
IPO Saham OBAT Modal Kerja
Pembelian
Bahan Baku,
63.0200004
20,661,007,147 Peningkatan 20,661,007,147 %
5776367
Fasilitas
Produksi, dan
Pemasaran
Thus to be informed accordingly.
Respectfully,
PT Brigit Biofarmaka Teknologi Tbk
Is Heriyanto
Direktur Utama
PT Brigit Biofarmaka Teknologi Tbk
Jalan Raya Tawangsari-Klaten, Rejosari, RT 01, RW 07, Kateguhan,
Phone : (0271) 5992141, Fax : , www.brigit.co.id
Sender Name Is Heriyanto
Function Direktur Utama
Date and Time 21-07-2025 11:06
Attachment 1. Penggunaan Dana IPO signed R.pdf
This is an official document of PT Brigit Biofarmaka Teknologi Tbk that does not require a signature as it was
generated electronically by the electronic reporting system. PT Brigit Biofarmaka Teknologi Tbk is fully responsible
for the information contained within this document.
Names mentioned 7 people and organisations named in the text · linked when the evidence is strong
unresolved
org
PT Bank Central
p.1 ×2
unresolved
org
Tiga Asia Tbk
p.1 ×2
unresolved
org
Tiga Indonesia Tbk
p.1 ×2
unresolved
person
Is Heriyanto
· Direktur Utama
p.2 ×2
unresolved
person
Function
· Direktur Utama
p.4
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.